Summary & Overview

CPT 11980: Subdermal Hormone Pellet Insertion

CPT code 11980 covers the subdermal insertion of hormone pellets that release synthetic testosterone and/or estradiol for management of menopausal symptoms in women and testosterone deficiency in men. This procedure is an outpatient, office-based or ambulatory practice service used in hormone replacement strategies that aim to provide sustained hormone delivery over weeks to months. Nationally, the code is relevant for payers and providers managing long-acting hormone therapies and for benefit design around procedure-based hormone delivery.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and which payers commonly cover or adjudicate claims for this service. The publication summarizes coverage considerations, common modifiers used in billing, and where data is not available in the input.

This content provides benchmarks and policy-focused context useful for billing managers, revenue cycle teams, and clinicians who refer or perform subdermal hormone pellet insertion. It highlights where further documentation and diagnosis mapping may be required for coverage determinations. Data not available in the input is explicitly noted so readers understand limitations of the source material.

AetnaBlue Cross Blue ShieldCignaUnitedHealthcareMedicare11980CPThormone-pelletsubdermal-insertionhormone-replacementoutpatient-proceduremenopause-treatmenttestosterone-deficiency

Billing Code Overview

CPT code 11980 describes the subdermal insertion of hormone pellets. The procedure involves inserting small synthetic hormone pellets, typically containing testosterone and/or estradiol, beneath the skin — most commonly in the subcutaneous tissue of the upper arm. The pellets release hormones over time to treat menopausal symptoms in women or testosterone deficiency in males.

Service type: Hormone pellet insertion (subdermal hormonal therapy)
Typical site of service: Outpatient clinic, physician office, or ambulatory procedure setting with access to minor procedure supplies and wound care resources.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical & Coding Specifications

Clinical Context

A 52-year-old female with symptomatic menopause presents to an outpatient women's health clinic for management of persistent vasomotor symptoms, sleep disturbance, and decreased libido despite trial of transdermal estrogen. After shared decision-making, the clinician recommends subdermal hormone pellet therapy. The procedure is performed in an ambulatory procedure room: informed consent is obtained, pre-procedure vitals and targeted history (contraindications, clotting history, current anticoagulants) are reviewed, and the insertion site (typically the subcutaneous tissue of the upper gluteal or lateral hip region or subdermal tissue of the upper arm) is marked. Local infiltration anesthesia is given, a small incision or trocar site is created, and one or more hormone pellets (testosterone and/or estradiol per prescription) are inserted subdermally. Hemostasis is achieved, the incision is closed with adhesive strips or a single suture if needed, and a sterile dressing is applied. Post-procedure instructions include activity restrictions, wound care, and follow-up for pellet performance and side-effect monitoring. Billing uses code 11980 for the subdermal insertion of hormone pellets; documentation includes indication, informed consent, number and type of pellets placed, site, anesthesia, any complications, and aftercare instructions.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable E/M service on the same day

Taxonomy Code	Specialty	Notes
`103K00000X`	Obstetrics & Gynecology	Common specialty performing hormone management and pellet insertion
`207RC0000X`	Dermatology	Performs subdermal procedures and cosmetic hormone pellet placements in some practices
`207L00000X`	Plastic Surgery	May perform insertions in cosmetic contexts or revise insertion sites
`208D00000X`	Family Medicine	Provides comprehensive care including hormone pellet therapy in primary care settings

ICD-10 Code	Description	Clinical Relevance
`N95.1`	Menopausal and other perimenopausal disorders	Primary indication for estrogen or combined pellet therapy to treat vasomotor and menopausal symptoms
`E29.1`	Testicular hypofunction	Indication for testosterone pellet insertion in males with testosterone deficiency
`E23.0`	Hypopituitarism	May cause sex hormone deficiencies managed with hormone replacement including pellets
`E89.4`	Postprocedural ovarian failure	Indicates loss of ovarian function treated with hormone replacement therapy
`E29.8`	Other testicular dysfunction	Additional male hypogonadal diagnoses appropriate for testosterone replacement

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99160`	Administration of local anesthesia; topical not elsewhere classified (Note: `99160` is an example—if payer-specific codes differ, use local guidance)	Used for reporting local anesthetic administration when separately reportable alongside pellet insertion
`12001`	Simple repair of superficial wounds of scalp, neck, axillae, external genitalia; 2.5 cm or less	Used if a small suture repair is required at the pellet insertion site
`99070`	Supplies and materials (except spectacles), used during the procedure	Used to report non-covered supplies associated with the insertion (sterile dressing, implantable pellets if allowed by payer)
`G0463`	Hospital outpatient clinic visit for assessment and management	When performed in a hospital outpatient clinic setting and clinic visit coding is required
`99213`	Established patient office visit, typically 15 minutes	Common E/M code for pre- or post-procedure evaluation when billed separately with modifier `25`

OpenPayer